RetroSense Therapeutics Granted Patent on Proprietary Method for Restoring Vision using Optogenetics

ANN ARBOR, Mich.--(BUSINESS WIRE)--The USPTO has granted U.S. patent Application No. 11/036,629, entitled “Method for Augmenting Vision in Persons Suffering from Photoreceptor Cell Degeneration” to RetroSense Therapeutics.